ALB and Sepsis: Notably, recent studies have suggested that early combination therapy with crystalloids and albumin in patients with sepsis, septic shock, or cardiogenic shock may confer a survival advantage over crystalloid therapy alone in the intensive care unit (ICU) [17–19].